AYAL Capital Advisors »

Biosante Pharmaceuticals shares owned by AYAL Capital Advisors

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by AYAL Capital Advisors from 13F filings

Historical chart of AYAL Capital Advisors investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by AYAL Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by AYAL Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $3.9M 60k 65.25
2025-03-31 $4.5M 67k 66.95

More positions owned by AYAL Capital Advisors

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Harsco Corporation (NVRI)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Orthofix Medical (OFIX)
Solaris Energy Infras Com Cl A Put Option (SEI)
Stoneridge (SRI)
Dupont De Nemours Call Option (DD)
Calumet (CLMT)
Gxo Logistics Incorporated Common Stock (GXO)
NetGear (NTGR)
American Axle & Manufact. Holdings (AXL)
Latham Group (SWIM)
Brookdale Senior Living (BKD)
Transalta Corp Call Option (TAC)

View all positions for AYAL Capital Advisors

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
Global Alpha Capital Management
Citadel Advisors
UBS Group
Dimensional Fund Advisors
Geode Capital Management
Deep Track Capital
Point72 Asset Management
Nuveen
Goldman Sachs Group
Arrowstreet Capital, Limited Partnership
William Blair Investment Management
Rubric Capital Management

View all funds holding Biosante Pharmaceuticals